首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2290870篇
  免费   157895篇
  国内免费   3465篇
耳鼻咽喉   33068篇
儿科学   75268篇
妇产科学   64650篇
基础医学   330687篇
口腔科学   64425篇
临床医学   197972篇
内科学   438727篇
皮肤病学   50220篇
神经病学   179111篇
特种医学   91640篇
外国民族医学   599篇
外科学   352987篇
综合类   45880篇
现状与发展   2篇
一般理论   580篇
预防医学   161909篇
眼科学   52604篇
药学   178195篇
  8篇
中国医学   5126篇
肿瘤学   128572篇
  2018年   23386篇
  2017年   18034篇
  2016年   20847篇
  2015年   23597篇
  2014年   31519篇
  2013年   47014篇
  2012年   65139篇
  2011年   68922篇
  2010年   40708篇
  2009年   37889篇
  2008年   65801篇
  2007年   71027篇
  2006年   72027篇
  2005年   70076篇
  2004年   67134篇
  2003年   65218篇
  2002年   63496篇
  2001年   110511篇
  2000年   113196篇
  1999年   95378篇
  1998年   25752篇
  1997年   22785篇
  1996年   22709篇
  1995年   21408篇
  1994年   19884篇
  1993年   18578篇
  1992年   73701篇
  1991年   71767篇
  1990年   70802篇
  1989年   68379篇
  1988年   62812篇
  1987年   61486篇
  1986年   58334篇
  1985年   55237篇
  1984年   40769篇
  1983年   34935篇
  1982年   20110篇
  1981年   17793篇
  1979年   37794篇
  1978年   26075篇
  1977年   22888篇
  1976年   20865篇
  1975年   23352篇
  1974年   27321篇
  1973年   26361篇
  1972年   25218篇
  1971年   23518篇
  1970年   21726篇
  1969年   21036篇
  1968年   19324篇
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
5.
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered.  相似文献   
6.
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation.  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号